BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2005
View Archived Issues
Human Genome Sciences monoclonal antibodies presented at recent congresses
Read More
Cell-based vaccine shows promise in prostate cancer
Read More
Eculizumab demonstrates long-term efficacy in paroxysmal nocturnal hemoglobinuria
Read More
Pioglitazone improves lipids more than rosiglitazone in type 2 diabetes patients
Read More
Tacrolimus ointment evaluated in allergic diseases
Read More
NeuroVax boosts FOXP3 expression in multiple sclerosis patients
Read More
Companies patent new therapies for depression, psychosis, etc.
Read More
Novel agents for the treatment of neurological disorders in early development
Read More
DA-9601 ameliorates asthma in mice
Read More
CBIQ activates mutant form of CFTR present in 75% of cystic fibrosis patients
Read More
Novel approach for asthma treatment via neurotrophin receptor antagonism
Read More
Lilly to discontinue four insulin products
Read More
NV-52 enters phase I for inflammatory bowel disease
Read More
NCI accepts Ceragenix cationic steroid antibiotic compounds for testing
Read More
Meridian Bioscience awarded license for parvovirus B19 vaccine
Read More
GlaxoSmithKline exercises option to LymphoStat
Read More
Development of ATL-146e for reperfusion injury supported by SBIR grant
Read More
PTC-124 receives orphan drug designations in Europe
Read More
Napo and Glenmark collaborate on crofelemer development
Read More
New data on gaboxadol in the treatment of primary insomnia
Read More
A gemcitabine-containing regimen improves quality of life of patients with early NSCLC
Read More
Phase II study of Prostvac-VF completes enrollment
Read More
FDA requests safety analysis for FTY-720
Read More
SPA for phase III study of Tocosol Paclitaxel in breast cancer
Read More
Sorafenib NDA filing complete
Read More
Novartis submits new Femara applications in U.S., Europe
Read More
Preos NDA accepted for review
Read More